本文へ移動
cccskills
無料GitHub で公開

es-check-one-year-hormone-therapy-surgery

Determines if a patient has completed ≥1 year of consistent and compliant hormone therapy for genital surgery approval. Triggers include patient requesting genital surgery and being on hormone therapy.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.1 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Check if ≥1 year compliant hormone therapy for surgery approval

STEP 1 — Gather Information

Collect hormone therapy start date, type, dosage, adherence pattern, assess for medical contraindications, and confirm patient’s desire to continue hormones and request for genital surgery.

STEP 2 — Rule In / Rule Out

Is hormone therapy desired and not medically contraindicated? If yes, proceed to Step 3; if no, surgery may be approved without the 1‑year requirement per guideline exception.

STEP 3 — Classify or Stratify

Has the patient completed ≥1 year of consistent and compliant hormone therapy? If yes, classify as eligible; if no, classify as not eligible.

STEP 4 — Decide

If eligible, approve genital gender‑affirming surgery; if not eligible, defer surgery until ≥1 year of therapy is achieved (unless hormone therapy is not desired or medically contraindicated, already addressed in Step 2).

Clinical Guardrails / Mimics / Pitfalls

Do not approve surgery based on patient request alone without verifying therapy duration and adherence; do not overlook intermittent use or non‑compliance; do not ignore medical contraindications that make hormone therapy unsafe; do not assume compliance without documentation; remember that the 1‑year rule is waived only when hormone therapy is not desired or medically contraindicated.

Concrete Clinical Example

A 26‑year‑on trans man requests metoidioplasty. He has been on testosterone 100 mg IM weekly for 10 months with good adherence, no contraindications, and desires hormones. Duration <1 year → defer surgery until 12‑month mark.

Source: Endocrine Society Clinical Practice Guideline, Endocrine Society, 2017, https://doi.org/10.1210/jc.2017-01658

TODO: consider adding scripts/calc.py for the es-check-one-year-hormone-therapy-surgery calculator

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する